A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the ...

Kenneth J. Chang, M.D., and Hoag Memorial Hospital Presbyterian are on a mission to make esophageal cancer a thing of the ...

The global gastroesophageal reflux disease therapeutics market is estimated to be valued at USD 4,986.2 million in 2025 and is projected to reach USD 7,033.5 million by 2035, registering a compound ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a ...

ProPhase Labs announces BE-Smart's validation for esophageal disease diagnostics, achieving over 95% success in detecting critical biomarkers. ProPhase Labs Inc. announced the successful ...

Eosinophilic Esophagitis Definition EoE is a disease characterized by a variety of upper gastrointestinal symptoms that occur in association with dense esophageal eosinophilia ( Box 1 ); its ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a ...

In Barrett's esophagus, normal esophageal squamous epithelium is replaced by a specialized columnar epithelium. [1] The condition is widespread and incurs patients with a 125-fold greater risk of ...

BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States Study shows >95% success rate, validating ...

BE-Smart offers a distinct advantage in the molecular diagnostics landscape for esophageal disease. Unlike imaging-based or DNA methylation approaches, BE-Smart measures real-time protein activity ...